Solvent Purity Impact on Esterification Efficiency in API Side-Chain Synthesis, identified by its specific CAS number, holds significant relevance in pharmaceutical manufacturing due to its critical role as a reagent. This compound is accurately characterized through its molecular formula and molecular weight, both essential for comprehensive traceability and quality control. For unambiguous identification, the substance is further defined by its IUPAC name and InChIKey, ensuring clarity in specification and procurement. Serving as a key intermediate or reagent, it supports the construction of active pharmaceutical ingredient (API) side chains, underlining its utility in synthetic organic chemistry and drug development workflows.
Regarding its physical and chemical properties, essential details such as boiling point, melting point, density, flash point, and vapor pressure are carefully evaluated to inform handling and process safety. Each of these specifications contributes to determining optimal process conditions and transport requirements, supporting both laboratory and industrial users in achieving consistent synthesis outcomes.
Compliance with regulatory standards is paramount for any reagent used in pharmaceutical applications. The REACH registration status, including the pertinent article number and recognized tonnage band, assures end-users of regulatory alignment within the European market. TSCA inventory verification, referencing the appropriate section, further guarantees recognition and legality for United States commerce and use. Where relevant, the compound’s inclusion under ICH guidelines is cited with full code and revision designation, along with any applicable specific impurity or elemental limits. For shipment and workplace safety, the most recent GHS hazard classification is reported, detailing all hazard phrases and the prescribed signal word for quick identification of risk. Any pharmacopeia listings, complete with chapter numbers, provide confirmation of suitability for pharmaceutical manufacture. Occupational exposure standards such as OSHA PEL or NIOSH REL are included when available, advising on worker safety in handling and process environments.
The value of this solvent or reagent is most apparent in its function within API side-chain synthesis, as referenced by its recognized use in pharmaceutical intermediates based upon accepted chemical industry indices. Its impact on the efficiency of esterification steps is especially crucial in multi-step syntheses, where side reactions or impurities may impede yield or product purity. Specific synthesis routes may exploit this chemical’s purity to drive selectivity in critical transformations necessary for manufacturing essential ingredients in various therapeutic agents.
Packaging formats are designed to accommodate the diverse scale of pharmaceutical and chemical manufacture. Commonly, the product is offered in sizes such as 25-kilogram drums, 200-kilogram drums, and intermediate bulk containers, ensuring flexibility for both research-scale and high-volume applications. Storage recommendations are derived from GHS stability data, typically suggesting cool, dry, and well-ventilated conditions away from incompatible substances. Shelf life expectations, following industry standards for this class of chemicals, help ensure the integrity of the reagent over time, optimizing both inventory control and process reliability.
For further information on the chemical structure, hazards, and regulatory coverage of Solvent Purity Impact on Esterification Efficiency in API Side-Chain Synthesis, authoritative sources include PubChem, the NIST Chemistry WebBook, the European Chemicals Agency (ECHA), and the EPA TSCA Inventory. These resources offer supplementary details and verifiable data to support decision-making throughout the chemical’s life cycle.
Sources:
https://pubchem.ncbi.nlm.nih.gov/compound/{cid}
https://webbook.nist.gov/cgi/cbook.cgi?Name={cas_number}
{echa_url}
https://www.epa.gov/tsca-inventory
Related Articles
